Regulaxis' targeted market segment is the elderly population but also athletes and obese persons to slow down or even stop disease progression by proposing a disruptive treatment (curative and symptomatic action) using a painless local administration mode at a competitive price. In fact, no efficient therapeutic tools to slow down the disease progression are available yet, it leads to a constant increase of knee replacement surgery.